Company PreMD Inc.

Equities

PREMF

CA74047Y1051

Pharmaceuticals

Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for PreMD Inc. -.--% -.--%

Business Summary

PreMD Inc is a Canada-based medical device company. The Company is engaged in the development and sale of non-invasive tests that detect early stage cardiovascular diseases and cancers. The Company’s products include PREVU Skin Sterol Test, ColorectAlert, LungAlert and Breast Cancer Test. The Company's PREVU Skin Sterol Test is a simple, non-invasive skin cholesterol test that is used in the determination of the risk assessment of coronary artery disease (CAD). The Company’s ColorectAlert is a screening test for colorectal cancer. LungAler is a screening test for colorectal cancer. Breast Cancer Test is a screening test for breast cancer. In addition to this, the Company has a number of products in its pipeline, which are in various stages of development. The products include the Color Measurement product, Other Cancers product, Colopath and the Genomics products.

Managers

Managers TitleAgeSince
Founder 63 92-11-08

Members of the board

Members of the board TitleAgeSince
Founder 63 92-11-08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 38,615,845 27,300,000 ( 70.70 %) 0 70.70 %

Company contact information

PreMD, Inc.

4211 Yonge Street Suite 242

M2P 2A9, Toronto

+

http://www.premdinc.com
address PreMD Inc.(PREMF)